How Not to Fix the F.D.A.

“How Not to Fix the F.D.A.,” by The Editorial Board, The New York Times.

A bill passed by the House and ostensibly designed to streamline the Food and Drug Administration is loaded with bad provisions and may not even be necessary. The Senate should either eliminate or rewrite the flawed . . . → Read More: How Not to Fix the F.D.A.

Visualizing Social Change: The Power of Graphic Arts

Originally published at Feminist Reflections on The Society Pages.

Graphic arts engage readers in a way text cannot. Told with sequences of pictures, along with narration and dialogue (often in the form of speech bubbles), graphic arts have become increasingly popular media for education and communication as well as social commentary. From disaster preparedness to . . . → Read More: Visualizing Social Change: The Power of Graphic Arts

After cancer treatment, I had to walk away from my life as I knew it

“After cancer treatment, I had to walk away from my life as I knew it,” by Sonja Koenig, The Globe and Mail.

Sonja Koenig lives in Yellowknife. She just completed a year’s sabbatical in New York.

It is back there somewhere in the morass of it all; the decision I made to just . . . → Read More: After cancer treatment, I had to walk away from my life as I knew it

The physician is the ultimate patient advocate

“The physician is the ultimate patient advocate,” by Kathryn A. Hughes MD, KevinMD.com.

Health systems and insurance companies increasingly dehumanize physicians, treating the highly skilled and highly trained professionals like pawns on a chess board, faceless and interchangeable. Physicians drop on and off of “preferred provider” lists in arbitrary and capricious fashion, destroying any relationship . . . → Read More: The physician is the ultimate patient advocate

Mammograms have a magical reputation. But they don’t save as many lives as you think

“Mammograms have a magical reputation. But they don’t save as many lives as you think,” by Ariana Eunjung Cha, The Washington Post.

Mammograms have an almost magical reputation among many women. At pink ribbon events, breast cancer survivors credit the screening tool as having saved their lives, and the U.S. government believes in their . . . → Read More: Mammograms have a magical reputation. But they don’t save as many lives as you think

Strong report questions effectiveness of breast cancer screening — but needed a discussion of study limitations

“Strong report questions effectiveness of breast cancer screening — but needed a discussion of study limitations” by Health News Review.

Health News Review (HNR) evaluates health news using systematic criteria to assess the extent to which a news story uses adequately addresses evidence.

HNR argues that a growing body of evidence suggests that screening . . . → Read More: Strong report questions effectiveness of breast cancer screening — but needed a discussion of study limitations

Appel à contribution « A tes côtés : prendre soin d'une personne atteinte du cancer du sein

[French]: Dans les dernières années, une vision édulcorée et banalisée du cancer du sein a dominé le discours public. Décrite comme un rituel de passage, la diagnose du cancer du sein est devenue, pour les personnes atteintes, une injonction à sourire, à avoir une attitude positive. Cette vision superficielle, encore présente dans plusieurs contextes, a . . . → Read More: Appel à contribution « A tes côtés : prendre soin d’une personne atteinte du cancer du sein

Early-stage breast cancer patients get too much testing: study

“Early-stage breast cancer patients get too much testing: study,” by Elizabeth Payne, Ottawa Citizen.

A study of 26,547 patients found that nearly 80 per cent of those with Stage 1 breast cancer and more than 90 per cent of those with Stage 2 had unnecessary tests, according to guidelines set out by Cancer Care Ontario, . . . → Read More: Early-stage breast cancer patients get too much testing: study

Clinical Trials Need Cancer Patients

“Clinical Trials Need Cancer Patients,” by Stan Collender, The New York Times.

I HAVE a very rare and aggressive type of skin cancer — Merkel cell carcinoma — for which there is no approved cure, and I’m participating in a clinical trial to deal with it. If successful, the trial will . . . → Read More: Clinical Trials Need Cancer Patients

Questions about Mayo Clinic deal with Minneapolis TV station

“Questions about Mayo Clinic deal with Minneapolis TV station,” by Trudy Lieberman, Health News Review.

Health News Review publishes a guest blog post by Trudy Lieberman, a veteran health care journalist who, for years, has tracked the cracks in the wall between health care news and health care advertising/sponsorship arrangements.

Back in 2007 writing for . . . → Read More: Questions about Mayo Clinic deal with Minneapolis TV station

Articles & Posts